Inicio
Explorar
nav.journalClub
Tendencias
Más
Synapse
⌘+K
Synapse
Idioma
Español
Español
Early Olfactory Recovery With Tezepelumab in CRSwNP: Mechanistic and Clinical Considerations | Synapse
April 19, 2026
Early Olfactory Recovery With Tezepelumab in CRSwNP: Mechanistic and Clinical Considerations
SK
Sushma Narsing Katkuri
Dr. Reddy's Laboratories (India)
VV
Varshini Vadhithala
Dr. D. Y. Patil Medical College, Hospital and Research Centre
SK
Sachin Kumar
Graphic Era University
Ver todo
Puntos clave
To explore the mechanisms and clinical impacts of tezepelumab on olfactory recovery in chronic rhinosinusitis with nasal polyps.
Investigated the olfactory recovery process in patients treated with tezepelumab.
Analyzed clinical outcomes related to olfactory function post-treatment.
Early signs of olfactory recovery observed in patients receiving tezepelumab.
Mechanistic insights into how tezepelumab aids in olfactory function restoration.
Resumen
The authors declare no conflicts of interest.
Preguntar a la IA
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Katkuri et al. (Fri,) studied this question.
synapsesocial.com/papers/69e472a8010ef96374d8eb2e
https://doi.org/https://doi.org/10.1002/alr.70167
Preguntar a la IA
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir